Emerging Growth Conference 88 December 11, 2025 9:05 AM ESTCompany ParticipantsJean-Marie Clouet - Vice President ...
NowVertical Group Inc. ( NOW:CA) Discusses Business Model, AI-Driven Solutions, Key Metrics and Growth Strategy December 10, 2025 2:00 PM EST ...
TipRanks on MSN
FitLife Brands unveils new corporate presentation
On December 10, 2025, FitLife Brands, Inc. introduced a new corporate presentation for business purposes. This move is part of their strategy to enhance communication and engagement with stakeholders, ...
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...
IBI3003 is a novel trispecific antibody targeting GPRC5D, BCMA and CD3 simultaneously. Its dual-targeting design against BCMA and GPRC5 aims to overcome single antigen escape in multiple myeloma (MM).
Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results